Ethosuximide: Clinical Trials

12 trials of Ethosuximide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 2 terminated, 2 unknown. 6 Phase 2, 3 Phase 3, 1 Early Phase 1, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Terminated 2, Unknown 1
Phase 33Recruiting 2, Completed 1
Early Phase 11Completed 1
Phase 11Terminated 1
Phase 41Unknown 1

Follow Ethosuximide: new trials by email Literature Review of Ethosuximide trials Research Report on Ethosuximide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain
Ethosuximide, Placebo - Peripheral Neuropathic Pain
Phase 2UnknownUniversity Hospital, Clermont-Ferrand642020-11-012023-01-06
Ketogenic Diet for New-Onset Absence Epilepsy
Modified Atkins Diet, Absence epilepsy medications - Absence Epilepsy, Ketogenic Dieting
Phase 3RecruitingJohns Hopkins University402020-08-102026-05-07
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
pentoxyifylline, Mebeverine, ethosuximide - IBS - Irritable Bowel Syndrome
Phase 3RecruitingTanta University602019-11-012020-01-03
Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.
Ethosuximide, Placebo, Escitalopram - Depressive Disorder, Treatment-Resistant
Early Phase 1CompletedZhejiang University162019-05-212025-06-18
Ethosuximide to Treat IBS
Ethosuximide, Placebo - Irritable Bowel Syndrome
Phase 2CompletedUniversity Hospital, Clermont-Ferrand1622018-02-082026-04-21
Population Pharmacokinetics of Antiepileptic in Pediatrics
Valproic acid, carbamazepine, phenobarbital - Epilepsy
CompletedAssistance Publique - Hôpitaux de Paris7532017-06-192025-11-20
Ketogenic Diet in Infants With Epilepsy (KIWE)
Ketogenic diet, Antiepileptic drug therapy - Epilepsy
Phase 4UnknownUniversity College, London1602015-01-012017-05-04
Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.
Zarontin® (ethosuximide) and Stodal® - Neuropathic Traumatic Pain, Pain NRS ≥ 4
Phase 2CompletedUniversity Hospital, Clermont-Ferrand1142014-03-012026-04-21
Comparison of a Drug and Placebo in the Prevention of Migraine Headaches
ethosuximide, placebo comparator - Headache, Migraine
Phase 1 / Phase 2TerminatedUS Department of Veterans Affairs52011-12-012015-08-19
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)
Ethosuximide, Placebo - Cancer, Peripheral Neuropathy
Phase 2CompletedRoyal Marsden NHS Foundation Trust152010-05-012016-05-26
Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)
Placebo, Ethosuximide - Complex Regional Pain Syndromes
Phase 2TerminatedMcGill University Health Centre/Research Institute of the McGill University Health Centre42008-09-012011-05-13
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
Ethosuximide, Lamotrigine, Valproic acid - Childhood Absence Epilepsy, Petit Mal Epilepsy
Phase 3CompletedChildren's Hospital Medical Center, Cincinnati4532004-07-012020-10-14

Conditions studied

Epilepsy (3)  ·  Epilepsy, Absence (2)  ·  Irritable Bowel Syndrome (2)  ·  Neuralgia (2)  ·  Pain (2)  ·  Chronic Pain (1)  ·  Complex Regional Pain Syndromes (1)  ·  Depression (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Migraine Disorders (1)  ·  Neoplasms (1)  ·  Peripheral Nervous System Diseases (1)  ·  Reflex Sympathetic Dystrophy (1)  ·  Seizures (1)  ·  Weight Gain (1)

Sponsors

University Hospital, Clermont-Ferrand (3)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Johns Hopkins University (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Royal Marsden NHS Foundation Trust (1)  ·  Tanta University (1)  ·  US Department of Veterans Affairs (1)  ·  University College, London (1)  ·  Zhejiang University (1)

Countries

France (4)  ·  United States (3)  ·  United Kingdom (2)  ·  Canada (1)  ·  China (1)  ·  Egypt (1)

Top investigators

Avital Cnaan, PhD (1)  ·  Eric H Kossoff, MD (1)  ·  Helen Cross, FRCP(UK) (1)  ·  Kathy L Gardner, MD (1)  ·  Mark A Ware, MD (1)  ·  Peter Adamson, MD (1)  ·  Sahar El-Haggar, Prof (1)  ·  Sahar Hegazy, Prof. (1)  ·  Sherief Abd-Elsalam, Ass. Prof. (1)  ·  Tracy A. Glauser, MD (1)  ·  Yi Xu, Doctor of Medicine (1)

Results publications

PMID 20200383, PMID 27986742, PMID 28446244, PMID 28720615, PMID 28916534, PMID 29577519, PMID 34726293, PMID 35221706, PMID 41505133

NIH funding

2016 (1), U01NS045803 (1)